Compound Profiles
Cyclic Glycine-Proline
IGF-1 Bioavailability Regulator & Neuroprotective Peptide
Competes with IGF-1 for IGFBP-3 binding, normalizing bioavailable IGF-1 levels. Acts as positive allosteric modulator of AMPA and GABA-A receptors.
MK-677
Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue
Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Cyclic Glycine-Proline with MK-677?
Yes, but with caution. Both Cyclic Glycine-Proline and MK-677 affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.
Is Cyclic Glycine-Proline and MK-677 safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting. Monitor accordingly.
What are the interactions between Cyclic Glycine-Proline and MK-677?
Both Cyclic Glycine-Proline and MK-677 affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.
How should I time Cyclic Glycine-Proline and MK-677?
Cyclic Glycine-Proline has a half-life of Extended stability (more stable than linear GPE precursor) and MK-677 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.